AstraZeneca Inks Agreement With Statkraft On Wind Power Deliveries
Portfolio Pulse from Benzinga Newsdesk
AstraZeneca has signed an agreement with Statkraft for wind power deliveries. The deal is part of AstraZeneca's commitment to achieve zero carbon emissions from its global operations by 2025.

August 09, 2023 | 7:26 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AstraZeneca's agreement with Statkraft for wind power deliveries could enhance its reputation as a sustainable company, potentially attracting environmentally conscious investors.
While the agreement with Statkraft is a positive step towards AstraZeneca's sustainability goals, it's not directly related to the company's core business operations or financial performance. Therefore, the impact on the stock price in the short term is likely to be neutral. However, it could enhance the company's reputation and appeal to environmentally conscious investors in the long term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100